Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
Share:
More In Science
8 Dead Due to Salmonella Linked to Cantaloupe
8 Dead Due to Salmonella Linked to Cantaloupe
FDA Approves First CRISPR Gene Editing Treatment
FDA Approves First CRISPR Gene Editing Treatment
FDA Expected to Approve First CRISPR Gene-Editing Treatment
The Food and Drug Administration is expected to approve the first CRISPR gene-editing therapy.
Study Examines High Blood Pressure Among Couples
A new study examines the prevalence of high blood pressure among couples.
Study: Wasabi Linked to Memory Boost
A study out of Japan found that a little bit of wasabi can improve memory.
Study: Eye Scans Provide Insights Into Kidney Health
A new study reveals that 3D eye scans can reveal important clues about your kidney health.
Be Well: Weightless Full Body Workout Routine
Weightless Full Body Workout Routine
New Treatment for Obesity Hits Pharmacy Shelves
Eli Lilly launched Zepbound, the latest product to join the exploding market for weight loss medications.
Company Offering DNA Data Storage
A new storage drive is using DNA to store data for 100 and 50 years.
